The association of IL28B genotype with peginterferon-α/ribavirin ( PR) treatment outcome and liver interferon-stimulated gene (ISG) expression is determined by HCV genotype

被引：0
|
作者：
Holmes, Jacinta A. [1 ,2 ]
Congiu, Mario [2 ]
Bonanazinga, Sara [3 ]
Sandhu, Manjeet K. [1 ]
Kia, Yin H. [1 ]
Bell, Sally [1 ]
Visvanathan, Kumar [4 ]
Sievert, William [4 ]
Bowden, Scott [3 ]
Desmond, Paul V. [1 ,2 ]
Thompson, Alexander J. [1 ,2 ]
机构：
[1] St Vincents Hosp, Fitzroy, Vic 3065, Australia
[2] Univ Melbourne, Carlton, Vic 3053, Australia
[3] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia
[4] Monash Univ, Monash Med Ctr, Clayton, Vic, Australia
来源：
HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1822
引用
收藏
页码：1042A / 1043A
页数：2
相关论文
共 50 条
  • [21] The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin
    Zobair M Younossi
    Aybike Birerdinc
    Mike Estep
    Maria Stepanova
    Arian Afendy
    Ancha Baranova
    Journal of Translational Medicine, 10
  • [22] The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin
    Younossi, Zobair M.
    Birerdinc, Aybike
    Estep, Mike
    Stepanova, Maria
    Afendy, Arian
    Baranova, Ancha
    JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
  • [23] Interferon-stimulated genes are associated with peginterferon/ribavirin treatment response regardless of IL28B alleles in hepatitis C virus/HIV-coinfected patients
    Rallon, Norma I.
    Lopez-Fernandez, Luis A.
    Isabel Garcia, Maria
    Benguria, Alberto
    Fiorante, Silvana
    Soriano, Vincent
    Benito, Jose M.
    AIDS, 2013, 27 (05) : 687 - 696
  • [24] COMPLETELY INDIVIDUALIZED TREATMENT DURATIONS WITH PEGINTERFERON-ALFA-2B AND RIBAVIRIN IN HCV GENOTYPE 1-INFECTED PATIENTS AND IMPORTANCE OF IL28B GENOTYPE (INDIV-2 STUDY)
    Sarrazin, Christoph
    Schwendy, Susanne
    Moeller, Bernd
    Dikopoulos, Nektarios
    Buggisch, Peter
    Encke, Jens
    Teuber, Gerlinde
    Goeser, Tobias
    Thimme, Robert
    Klinker, Hartwig
    Boecher, Wulf O.
    Schulte-Frohlinde, Ewert
    Prinzing, Renate
    Berg, Thomas
    Zeuzem, Stefan
    HEPATOLOGY, 2010, 52 (04) : 384A - 384A
  • [25] IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon/ribavirin for chronic hepatitis C genotype 1
    Lindh, M.
    Lagging, M.
    Arnholm, B.
    Eilard, A.
    Nilsson, S.
    Norkrans, G.
    Soderholm, J.
    Wahlberg, T.
    Wejstal, R.
    Westin, J.
    Hellstrand, K.
    JOURNAL OF VIRAL HEPATITIS, 2011, 18 (07) : E325 - E331
  • [26] PREDICTION OF RELAPSE AFTER PEGINTERFERON ALFA-2B/RIBAVIRIN THERAPY IN CHRONIC HCV GENOTYPE 1 PATIENTS IS DEPENDENT ON MINIMAL RESIDUAL VIREMIA BUT NOT ON IL28B GENOTYPE
    Wiegand, J.
    Neumann, K.
    Boehm, S.
    Weich, V.
    Klinker, H.
    Moeller, B.
    Rasenack, J.
    Hinrichsen, H.
    Gerlach, T.
    Spengler, U.
    Buggisch, P.
    Sarrazin, C.
    Berg, T.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S533 - S533
  • [27] IMPACT OF IL28B GENOTYPE ON HCV TREATMENT DECISION IN A LARGE FRENCH COHORT
    Renou, C.
    Allegre, T.
    Ouzan, D.
    Bourliere, M.
    Delasalle, P.
    Lafeuillade, A.
    Cadranel, J-F
    Haddad, N.
    Asselah, T.
    Penaranda, G.
    Sauser-Chirat, F.
    Khiri, H.
    Halfon, P.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S338 - S338
  • [28] Association between the IL28B genotype and hepatitis C viral kinetics in the early days of treatment with pegylated interferon plus ribavirin in HIV/HCV co-infected patients with genotype 1 or 4
    Rivero-Juarez, Antonio
    Camacho Espejo, Angela
    Perez-Camacho, Ines
    Neukam, Karin
    Caruz, Antonio
    Antonio Mira, Jose
    Mesa, Pilar
    Garcia-Lazaro, Milagros
    Torre-Cisneros, Julian
    Antonio Pineda, Juan
    Rivero, Antonio
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (01) : 202 - 205
  • [29] The Recipient IL28B Genotype Influences the Severity of HCV Recurrence after Liver Transplantation
    Cisneros, Elisa
    Banos, Isolina
    Citores, Maria-Jesus
    Canizares, Maria
    Cuervas-Mons, Valentin
    Vilches, Carlos
    LIVER TRANSPLANTATION, 2011, 17 (06) : S147 - S147
  • [30] INTERFERON-STIMULATED GENE EXPRESSION IS ASSOCIATED WITH TREATMENT RESPONSE TO FALDAPREVIR PLUS PEGYLATED INTERFERON α-2a AND RIBAVIRIN IN PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION
    Datsenko, Y.
    Baum, P.
    Schirmbeck, R.
    Stern, J. O.
    Sha, N.
    Steinmann, G. G.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S309 - S310
12345